• Mashup Score: 48

    Purpose Identifying pathogenic non-coding variants in individuals with developmental disorders (DD) is challenging due to the large search space. It is common to find a single protein-altering variant in a recessive gene in DD patients, but the prevalence of pathogenic non-coding ;second hits; in trans with these is unknown. Methods In 4,073 genetically undiagnosed rare disease trio probands…

    Tweet Tweets with this article
    • RT @nickywhiffin: 🚨 New preprint 🚨 https://t.co/ffVYUumnQ1 "Non-coding variants are a rare cause of recessive developmental disorders in t…

  • Mashup Score: 1

    Mucosal antibodies play a key role in the protection against SARS-CoV-2 infection in the upper respiratory tract, and potentially in limiting virus replication and therefore onward transmission. While systemic immunity to SARS-CoV-2 is well understood, little is known about the antibodies present on the nasal mucosal surfaces. In this study, we evaluated SARS-CoV-2 mucosal antibodies in response…

    Tweet Tweets with this article
    • RT @gcevd: And here’s the preprint related to this work https://t.co/qdHIAELwNA

  • Mashup Score: 0

    The cost of drug discovery and development is driven primarily by failure, with just ∼10% of clinical programs eventually receiving approval. We previously estimated that human genetic evidence doubles the success rate from clinical development to approval. In this study we leverage the growth in genetic evidence over the past decade to better understand the characteristics that distinguish…

    Tweet Tweets with this article
    • Refining the impact of genetic evidence on clinical success https://t.co/O6esLW5imQ via @cureffi et al https://t.co/S2AX5IMcB2

  • Mashup Score: 1

    Infections can lead to persistent or long-term symptoms and diseases such as shingles after varicella zoster, cancers after human papillomavirus, or rheumatic fever after streptococcal infections(1,2). Similarly, infection by SARS-CoV-2 can result in Long COVID, a condition characterized by symptoms of fatigue and pulmonary and cognitive dysfunction(3-5). The biological mechanisms that contribute…

    Tweet Tweets with this article
    • Another one of the visionary studies that the UK funding agencies supported: properly powered assessment of possible host genetic factors that related to long COVID. Over 6000 long COVID cases and 1 M controls. https://t.co/bw1THXed51

  • Mashup Score: 88

    Infections can lead to persistent or long-term symptoms and diseases such as shingles after varicella zoster, cancers after human papillomavirus, or rheumatic fever after streptococcal infections(1,2). Similarly, infection by SARS-CoV-2 can result in Long COVID, a condition characterized by symptoms of fatigue and pulmonary and cognitive dysfunction(3-5). The biological mechanisms that contribute…

    Tweet Tweets with this article
    • Variants in FOXP4, the 1st gene identified to be associated with #LongCovid, from over 6,400 cases and >1 million controls https://t.co/phZoayDht6 https://t.co/CjRvMGVSrl

  • Mashup Score: 0

    The root causes of dementia are still largely unclear, and the medical community lacks highly effective preventive and therapeutic pharmaceutical agents for dementia despite large investments into their development. There is growing interest in the question if infectious agents play a role in the development of dementia, with herpesviruses attracting particular attention. To provide causal as…

    Tweet Tweets with this article
    • The study is posted as a pre-print here: https://t.co/Z1aLYjMg6c

  • Mashup Score: 1

    Long non-coding RNAs (lncRNAs) are known to perform important regulatory functions. Large-scale whole genome sequencing (WGS) studies and new statistical methods for variant set tests now provide an opportunity to assess the associations between rare variants in lncRNA genes and complex traits across the genome. In this study, we used high-coverage WGS from 66,329 participants of diverse…

    Tweet Tweets with this article
    • Our preprint led by @kyleyx_w @gina_peloso uses whole genome sequencing to uncover the role of rare variants in the transcripts of lncRNAs for lipids https://t.co/Re2mu1Y8Xp @medrxivpreprint https://t.co/rNxa6WEPBA

  • Mashup Score: 2

    Genome-wide association studies (GWAS) have underrepresented individuals from non-European populations, impeding progress in characterizing the genetic architecture and consequences of health and disease traits. To address this, we present a population-stratified phenome-wide GWAS followed by a multi-population meta-analysis for 2,068 traits derived from electronic health records of 635,969…

    Tweet Tweets with this article
    • RT @jorsmo: Diversity and Scale: Genetic Architecture of 2,068 Traits in the VA Million Veteran Program https://t.co/PlnZWJB2bs

  • Mashup Score: 0

    Myalgic Encephalomyelitis/ Chronic Fatigue syndrome (ME/CFS) is a complex, debilitating, long-term illness without a diagnostic biomarker. ME/CFS patients share overlapping symptoms with long COVID patients, an observation which has strengthened the infectious origin hypothesis of ME/CFS. However, the exact sequence of events leading to disease development is largely unknown for both clinical…

    Tweet Tweets with this article
    • Biomarker for severity of both ME/CFS and Long COVID: ⬆️circulating FN1 and ⬇️⬇️ of (n)IgM-FN1 NEW @BhupeshPrusty lab preprint: Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in #MECFS and #LongCOVID https://t.co/RNqwGb2BLn https://t.co/ldMljNsZuP

  • Mashup Score: 0

    Background Observational vaccine effectiveness (VE) studies based on real-world data are a crucial supplement to initial randomized clinical trials of Coronavirus Disease 2019 (COVID-19) vaccines. However, there exists substantial heterogeneity in study designs and statistical methods for estimating VE. The impact of such heterogeneity on VE estimates is not clear. Methods We conducted a two-step…

    Tweet Tweets with this article
    • Review of 53 studies estimating VE of the 1st booster, and for the 2nd booster. The first monovalent (OG) booster and the bivalent (OG+BA.5) booster appear to offer strong protection against severe COVID-19. However, 2nd monovalent (OG) booster did not. https://t.co/prl5cckPwa